News | October 13, 2023
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
The composition of ORAAL is protected by a granted patent in India until November 2033
The composition of ORAAL is protected by a granted patent in India until November 2033
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Alignment of carbon-fiber can be controlled during the 3D printing process
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
Subscribe To Our Newsletter & Stay Updated
